Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Overactive Bladder Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Overactive Bladder Therapeuticsmarket, defines the market attractiveness level of Overactive Bladder Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Overactive Bladder Therapeutics industry, describes the types of Overactive Bladder Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Overactive Bladder Therapeutics market and the development prospects and opportunities of Overactive Bladder Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Overactive Bladder Therapeutics market in Chapter 13.
By Player:
Pfizer
Astellas Pharma
Allergan
Teva (Activas)
Johnson & Johnson
By Type:
Anticholinergics
Mirabegron
Botox
By End-User:
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Overactive Bladder Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Overactive Bladder Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Overactive Bladder Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Overactive Bladder Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Overactive Bladder Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Overactive Bladder Therapeutics Consumption (2017-2022)
-
7.2 United States Overactive Bladder Therapeutics Consumption (2017-2022)
-
7.3 Europe Overactive Bladder Therapeutics Consumption (2017-2022)
-
7.4 China Overactive Bladder Therapeutics Consumption (2017-2022)
-
7.5 Japan Overactive Bladder Therapeutics Consumption (2017-2022)
-
7.6 India Overactive Bladder Therapeutics Consumption (2017-2022)
-
7.7 South Korea Overactive Bladder Therapeutics Consumption (2017-2022)
8 Region and Country-wise Overactive Bladder Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Overactive Bladder Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Overactive Bladder Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Overactive Bladder Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Overactive Bladder Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Overactive Bladder Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Overactive Bladder Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Overactive Bladder Therapeutics Consumption Forecast (2022-2028)
9 Global Overactive Bladder Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Overactive Bladder Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anticholinergics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Mirabegron Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Botox Consumption and Growth Rate (2017-2022)
-
9.2 Global Overactive Bladder Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Idiopathic Overactive Bladder Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Neurogenic Overactive Bladder Consumption and Growth Rate (2017-2022)
10 Global Overactive Bladder Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Overactive Bladder Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Mirabegron Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Botox Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Overactive Bladder Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Idiopathic Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Neurogenic Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
11 Global Overactive Bladder Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Overactive Bladder Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Overactive Bladder Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Overactive Bladder Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Overactive Bladder Therapeutics Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Overactive Bladder Therapeutics Product and Service
-
14.2 Astellas Pharma
-
14.2.1 Astellas Pharma Company Details
-
14.2.2 Astellas Pharma Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astellas Pharma Overactive Bladder Therapeutics Product and Service
-
14.3 Allergan
-
14.3.1 Allergan Company Details
-
14.3.2 Allergan Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Allergan Overactive Bladder Therapeutics Product and Service
-
14.4 Teva (Activas)
-
14.4.1 Teva (Activas) Company Details
-
14.4.2 Teva (Activas) Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva (Activas) Overactive Bladder Therapeutics Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Overactive Bladder Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Overactive Bladder Therapeutics
-
Figure Overactive Bladder Therapeutics Picture
-
Table Global Overactive Bladder Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Overactive Bladder Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Overactive Bladder Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Overactive Bladder Therapeutics Consumption by Country (2017-2022)
-
Figure United States Overactive Bladder Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Overactive Bladder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Overactive Bladder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Overactive Bladder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Overactive Bladder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Overactive Bladder Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Overactive Bladder Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Overactive Bladder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Overactive Bladder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Overactive Bladder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Overactive Bladder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Overactive Bladder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Overactive Bladder Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticholinergics Consumption and Growth Rate (2017-2022)
-
Figure Global Mirabegron Consumption and Growth Rate (2017-2022)
-
Figure Global Botox Consumption and Growth Rate (2017-2022)
-
Figure Global Idiopathic Overactive Bladder Consumption and Growth Rate (2017-2022)
-
Figure Global Neurogenic Overactive Bladder Consumption and Growth Rate (2017-2022)
-
Figure Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mirabegron Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Botox Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Idiopathic Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurogenic Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Overactive Bladder Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Overactive Bladder Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Overactive Bladder Therapeutics Product and Service
-
Table Astellas Pharma (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Overactive Bladder Therapeutics Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Overactive Bladder Therapeutics Product and Service
-
Table Teva (Activas) (Foundation Year, Company Profile and etc.)
-
Table Teva (Activas) Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva (Activas) Overactive Bladder Therapeutics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Overactive Bladder Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Overactive Bladder Therapeutics Product and Service
-
